Serial volumetric (three-dimensional) intravascular ultrasound analysis of restenosis after directional coronary atherectomy  by de Vrey, Evelyn A et al.
Serial Volumetric (Three-Dimensional) Intravascular Ultrasound
Analysis of Restenosis After Directional Coronary Atherectomy
EVELYN A. DE VREY, MD,* GARY S. MINTZ, MD, FACC,* CLEMENS VON BIRGELEN, MD,‡
TAKESHI KIMURA, MD, FACC,† MASAKIYO NOBOYOSHI, MD, FACC,†
JEFFREY J. POPMA, MD, FACC,* PATRICK W. SERRUYS, MD, PHD, FACC,‡
MARTIN B. LEON, MD, FACC*
Washington, DC; Kitakyushu, Japan; and Rotterdam, The Netherlands
Objectives. We report the use of three-dimensional (volumetric)
intravascular ultrasound (IVUS) analysis to assess serial changes
after directional coronary atherectomy (DCA).
Background. Recent serial planar IVUS studies have described
a decrease in external elastic membrane (EEM) area following
catheter-based intervention as an important mechanism of late
lumen renarrowing.
Methods. Thirty-one patients with de novo native coronary
lesions treated with DCA in the Serial Ultrasound Restenosis
(SURE) Trial and in Optimal Atherectomy Restenosis Study
(OARS) were enrolled in this study. Serial IVUS was performed
before and after intervention and at 6 months’ follow-up. In a
subgroup of 18 patients from the SURE trial, IVUS was also
performed at 24 h and at 1 month postintervention. Segments,
20-mm-long (200 image slices), were analyzed using a previously
validated three-dimensional, computerized, automated edge-
detection algorithm. The EEM, lumen, and plaque1media
(P1M 5 EEM2lumen) volumes were calculated.
Results. At follow-up, lumen volume was smaller than at
postintervention (159 6 69 mm3 vs. 179 6 49 mm3, p 5 0.0003).
From postintervention to follow-up, there was a decrease in EEM
volume (377 6 107 to 352 6 125 mm3, p < 0.0001), but no change
in P1M volume (p 5 0.52). The D lumen volume correlated
strongly with DEEM volume (r 5 0.842, p < 0.0001), but not with
DP1M volume. In the 18 patients from the SURE Trial, the
decrease in lumen and EEM volumes occurred late, between 1
month and 6 months of follow-up.
Conclusions. Volumetric IVUS analysis demonstrated that late
lumen volume loss following DCA was a result of a decrease in
EEM volume. This was a late event, occurring between 1 and 6
months’ postintervention.
(J Am Coll Cardiol 1998;32:1874–80)
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Restenosis remains the major problem after catheter-based
interventions such as directional coronary atherectomy (DCA)
(1,2). Animal models, human necropsy studies, and analyses of
retrieved atherectomy specimens originally suggested that an
exaggeration of the normal reparative processes following
angioplasty-induced local vessel trauma leads to uncontrolled
smooth muscle cell proliferation and restenosis (3–6). Con-
versely, recent studies using histopathologic analysis in animals
and planar intravascular ultrasound (IVUS) imaging in hu-
mans have suggested that a decrease in arterial area may be
more important than neointimal hyperplasia as a mechanism
of restenosis (7–14).
Using IVUS allows transmural, tomographic imaging of
coronary arteries in humans in vivo, providing insights into the
pathology of coronary artery disease by defining vessel wall
geometry and major components of the atherosclerotic plaque.
However, when performing natural history studies using cross-
sectional area (CSA) IVUS analysis, subjective decisions re-
garding image slice selection may bias the results (5,6,14).
Also, previous studies assessing long-term effects of catheter-
based procedures typically included patients treated with
different techniques (5,6). In the current study we used
independent serial volumetric IVUS analysis to determine
the relative contributions of changes in plaque and arterial
volumes to late lumen loss after DCA. Volumetric analysis
was performed with a previously validated and published
automated, three-dimensional (volumetric) contour detec-
tion system (15,16).
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Methods
Patient population. Serial volumetric IVUS was used to
study de novo native coronary lesions in 31 patients (one lesion
per patient) treated with successful directional coronary
atherectomy (DCA). Patients were selected from two serial
atherectomy studies. The Optimal Atherectomy Restenosis
Study (OARS) enrolled a total of 200 patients and included
serial IVUS pre-DCA, post-DCA, postadjunct percutaneous
transluminal coronary angioplasty (PTCA) and at follow-up.
The purpose of the IVUS substudy of OARS was to 1)
measure the contribution of tissue removal to lumen improve-
ment after DCA and after adjunct PTCA, 2) determine the
optimum IVUS and angiographic end points of DCA, and 3)
assess the mechanism of restenosis after DCA. The results of
OARS and its IVUS substudy have been published (14,17).
The Serial Ultrasound Restenosis (SURE) Trial enrolled 61
patients treated with DCA or PTCA and included serial IVUS
preintervention, postintervention, 24 h postintervention, 1
month postintervention, and 6 months’ postintervention. Its
purpose was to 1) confirm the existence and 2) define the time
course of remodeling (change in arterial dimensions) after
DCA or PTCA. The results of SURE have also been published
(8).
The patient cohort in the current study was selected after
examining the IVUS and angiographic studies from OARS and
SURE to identify all of the patients who met the following
criteria: 1) successful DCA, 2) high-quality IVUS images with
limited target lesion calcium throughout the length of the
lesion, 3) angiographically noncurved target segments, 4)
nonostial lesion location, and 5) the same 20-mm-long segment
of artery imaged at each time point with at least 5 mm of vessel
proximal and distal to the minimum lumen area preinterven-
tion, postintervention, and at follow-up. The threshold for
excluding cases based on excessive calcification was one quad-
rant (90°) of uninterrupted calcium over a length of $5mm.
Because volumetric IVUS analysis was not a planned part of
either trial, most patients were excluded from the current
analysis because of the last criteria. There were 25 men and 6
women (mean age 61 6 9 years); lesion location was left
anterior descending artery in 20, left circumflex artery in 4, and
right anterior descending coronary artery in 7 patients.
The DCA procedure was performed according to standard
protocols using an average number of 27.0 6 9.6 cuts. In three
patients predilatation was performed before DCA (but after
the initial IVUS run). Adjunct balloon angioplasty was per-
formed in 21 patients (68%) at a maximal pressure of 11.9 6
4.9 atm using a mean balloon size of 3.7 6 0.5 mm; this was
then followed by the final IVUS run. Patient and lesion
characteristics of the subgroup of 31 individuals showed no
significant difference compared to the complete study popula-
tion. All patients gave written informed consent as approved by
the local Medical Ethics committees.
Quantitative coronary angiographic (QCA) analysis. All
cineangiograms were analyzed by an independent core angio-
graphic laboratory using a quantitative automated edge detec-
tion algorithm (ARTREK, Quantitative Cardiac Systems). The
outer diameter of the contrast-filled catheter was used for
calibration. The minimum lumen diameter (MLD), reference
diameter, and percent diameter stenosis (DS) were measured
from multiple projections, and the results from the “worst
view” were recorded.
IVUS imaging protocol. All IVUS imaging runs were per-
formed after administration of 100 to 200 mcg intracoronary
nitroglycerin. The imaging system used incorporated a single-
element, 30-MHz beveled transducer within either a 2.9F-long
monorail catheter (having a common distal lumen design that
accommodated the guide wire or transducer, but not both) or
a 3.2F short monorail catheter (CardioVascular Imaging Sys-
tems). The imaging catheter was advanced beyond the target
lesion, and the transducer was withdrawn slowly within the
stationary imaging sheath using a motorized pull-back device
at a constant speed of 0.5 mm/s. The accuracy of this motorized
transducer pullback device has been validated in vivo (18). All
IVUS studies were recorded on 0.5 in. (1.27 cm) high-
resolution s-VHS tape for off-line analysis.
Quantitative computerized IVUS analysis. All IVUS tapes
from OARS and SURE were submitted for independent
analysis. This individual was experienced in the use of the
computerized three-dimensional analysis system and was
blinded to the angiographic and clinical results of both trials as
well as to the previously published planar IVUS findings. This
individual was responsible for screening the IVUS studies to
exclude those that did not meet all inclusion criteria (see
preceding discussion). All segments analyzed had a length of
20 mm (equivalent to 40 s of videotape at a pullback speed of
0.5 mm/s). The segments analyzed included the minimal lumen
area at preintervention, postintervention, and follow-up with at
least 5 mm of vessel proximal and distal. By using one or more
reproducible axial landmarks (for example, the aorto-ostial
junction, large proximal and/or distal side branches, or unusu-
ally shaped calcium deposits) and a known pullback speed,
identical 20-mm-long segments on serial studies could be
identified for comparative analysis. If necessary, the serial
studies were analyzed side-by-side to ensure that the same
20-mm-long segments were measured.
The IVUS image analysis has been validated previously
(19–22). The external elastic membrane (EEM) is a reproduc-
ible measure of the arterial boundary and was identified by the
leading edge between the hypoechoic media and the hypere-
choic adventitia. Because media thickness cannot be measured
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accurately, plaque1media (P1M) was used as a measurement
of atherosclerotic plaque (23).
The IVUS analysis was performed off-line using a previ-
ously validated computerized, quantitative analysis system
developed at the Thoraxcenter Rotterdam (15,16). Validation
of this algorithm has been reported both 1) in a tubular
phantom and 2) within atherosclerotic human coronary artery
segments studied in vitro in which there were good correlations
with the corresponding histologic sections (r 5 0.94, 0.88 and
0.80 for areas and 0.98, 0.91 and 0.83 for volumes, respectively)
and with manual tracing of IVUS images (r 5 0.97 for CSA
and 0.99 for volume) and showed low mean differences of
63.7%. In vivo, there were high intraobserver and interob-
server correlations for both area measurements (r 5 0.95 to
0.98) and volume measurements (r 5 0.99) with small mean
differences (20.87% to 1.08%). Standard deviations for lumen,
P1M and arterial measurements did not exceed 7.3%, 10.8%
and 4.4% (CSA) and 2.7%, 2.8% and 0.7% (volume), respec-
tively.
Using this algorithm, 200 IVUS images were digitized from
the videotapes at a frame rate of 10/s. The reconstructed
segment length (20 mm) was thus defined by the speed of the
motorized transducer pullback device during image acquisition
(0.5 mm/s) and by the digitization frame rate (10/s).
The automated processing technique was based on the
interaction between longitudinal and cross-sectional contours.
Longitudinal tracings of the lumen and media-adventitia inter-
faces facilitated automated contour detection on the cross-
sectional IVUS images. To perform the analysis, the auto-
mated boundary detection algorithm first approximated the
lumen-intima and media-adventitia interfaces on all 200 image
slices. Two longitudinal planes were then constructed and
manually edited. This updated information was used to per-
form a second automatic contour detection sequence. Subse-
quently, the set of 200 cross-sectional images was visually
checked and again manually edited where necessary. Finally,
the volumetric results were computed from the edited cross-
sectional image data set (Fig. 1). This procedure has been
reported previously in detail (15,16,24,25).
Statistical analysis. StatView 4.5 was used for the statisti-
cal analysis. Categorical variables are presented as frequencies
and compared using chi-square statistics. Continuous variables
are presented as mean values 6 1 SD. Continuous variables
are compared using regression analysis. An ANOVA for
repeated measurements was used to evaluate potential differ-
ences in volumetric measurements over the time course of the
study. Post hoc, paired Student’s t-test with the Bonferroni
correction was used to compare paired measurements of EEM,
lumen and P1M volumes. A p , 0.05 value was considered to
be statistically significant, except for the post hoc comparisons
when statistical significant required a p , 0.05/number of
comparisons (p , 0.05/3 or p , 0.017 for the overall cohort of
31 patients and p , 0.05/5 or p , 0.01 for the 18 patients
studied preintervention, postintervention, at 24 h, at 1 month,
and at 6 months) (26,27).
Results
Serial angiographic results. The MLD increased signifi-
cantly from 1.04 6 0.30 mm preintervention to 2.61 6 0.20 mm
postintervention (p , 0.0001). The DS decreased from 66 6
12% to 20 6 7% (p , 0.0001). At 6 months’ follow-up, the
overall MLD had decreased to 1.81 6 0.82 mm (p , 0.0001)
and diameter stenosis increased to 43 6 25% (p , 0.0001).
Eleven lesions (35%) had a diameter stenosis .50% at follow-
up.
Serial volumetric IVUS measurements. The lumen volume
increased significantly from 115 6 44 mm3 preintervention to
175 6 44 mm3 postintervention (p , 0.0001). Both tissue
removal (P1M decrease from 201 6 85 to 177 6 77 mm3, p ,
0.0001) and vessel expansion (EEM increase from 315 6 97 to
351 6 98 mm3, p , 0.0001) contributed to lumen improve-
ment.
At follow-up, mean lumen volume was smaller than at
postintervention (145 6 61 mm3 vs. 175 6 44 mm3, p 5
0.0003). There was a decrease in EEM volume (from 351 6
Figure 1. Schematic drawing of automated contour detection of
lumen-tissue and media-adventitia boundaries in a coronary segment.
The processing technique is based on the concept that longitudinal
contours facilitate the automated contour detection on the cross-
sectional intravascular ultrasound (IVUS) images by defining the
center and the range of the boundary-searching process. After
digitalization of a motorized IVUS video recording, two longitudinal
sections (X,Y) are processed. The tissue-lumen and media-adventitia
boundaries in these longitudinal sections are automatically traced.
Subsequently, this information is used as points to define regions-of-
interest in the cross-sectional image to guide a second automatic
contour detection process. Finally, the volumetric results are calcu-
lated from the contour data of the cross-sectional IVUS images.
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98 mm3 to 318 6 112 mm3, p 5 0.0001), but no change in P1M
volume (177 6 77 vs. 174 6 72 mm3, p 5 0.52) (Fig. 2). A
single example of the output of the analysis system is shown in
Figure 3. Figure 4 shows that the change in lumen volume
correlated with the change in EEM volume from postinterven-
tion to follow-up (r 5 0.842, p , 0.0001), but not with the
change in P1M volume (r 5 0.244, p 5 0.186).
At follow-up, the EEM volume was less than at preinter-
vention in 17 lesions: in 9/11 restenotic lesions (82%) and in
8/20 nonrestenotic lesions (40%, p 5 0.0252). At follow-up,
16/31 lesions had an increase in P1M volume (compared to
postintervention). An increase in P1M volume (postinterven-
tion to follow-up) was similar in restenotic vs. nonrestenotic
lesions (p 5 0.3205).
SURE trial substudy. Table 1 shows the volumetric IVUS
results of the 18 patients studied preintervention, postinterven-
tion, at 24 h, at 1 month, and at 6 months. Of note, the decrease
in lumen and EEM volumes occurred between 1 month and 6
months of follow-up (both p , 0.0001). Lumen volume changes
correlated with changes in EEM volume at each interval during
the follow-up period (r 5 0.903, p , 0.0001), but not with changes
in plaque volume (r 5 0.246, p 5 0.073) (Fig. 5).
Figure 2. Plots showing individual IVUS measure-
ments of external elastic membrane (EEM), lu-
men, and plaque1media (P1M) volumes post-
intervention (Post) and at follow-up (6 mo FU) in
the entire cohort of 31 patients.
Figure 3. A serial (preintervention, postintervention, and 6-month
follow-up) three-dimensional IVUS analysis is shown. Lesion length is
plotted on the x-axis. The external elastic membrane (EEM) cross-
sectional area over the length of the lesion is shown by the upper line,
and the lumen cross-sectional area over the length of the lesion is
shown by the lower line, and the plaque1media (P1M) cross-sectional
area over the length of the lesion is shown by both the gray area and
by the dark black line. Preintervention, the minimum lumen cross-
sectional area, is at the 5-mm length marker. In this example, the
increase in lumen during the directional atherectomy procedure
(DCA) is almost entirely the result of a decrease in P1M cross-
sectional area at the center of the lesion. At follow-up, the stenosis
recurs with minimum lumen cross-sectional area again located at the
5-mm length marker. There has been a reduction in EEM cross-
sectional area over the length of the lesion, but especially from the
0-mm to the 15-mm length marker. There has been no change in P1M
cross-sectional area over the length of the lesion. Thus, recurrence was
entirely the result of negative arterial remodeling (decrease in EEM).
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Discussion
The current volumetric IVUS analysis substantiated the
previously published planar IVUS findings implicating a de-
crease in arterial dimensions as an important mechanism of
restenosis in nonstented lesions. The main results of the
current study were 1) changes in lumen volumes after DCA
correlated with the changes in EEM volumes, not with the
changes in P1M volumes, and 2) late lumen volume loss (and,
therefore, restenosis) occurred between 1 month and 6
months’ postintervention when the decrease in EEM volume
occurred. No significant increase in plaque volume occurred at
any time during this study.
Previously published planar IVUS findings. The initial
report of a decrease in EEM CSA postintervention included
221 nonstented lesions treated with a variety of catheter-based
techniques alone or in combination (7). In this initial report,
70% to 75% of late lumen loss was attributed to a decrease in
EEM CSA; and the change in lumen CSA correlated more
strongly with the change in EEM CSA (r 5 0.751) than with
the change in P1M CSA (r 5 0.284). There appeared to be
one exception to these findings: diabetic patients (28). In
diabetic patients, there was a trend toward a significant in-
crease in P1M CSA (1.3 6 2.6 mm2 vs. 0.6 6 2.5 mm2 in
nondiabetic patients, p 5 0.0720). This was especially true
when just the restenotic lesions were considered: 2.3 6
2.8 mm2 vs. 0.9 6 2.5 mms (diabetic vs. nondiabetic patients,
p 5 0.0191).
The importance of a decrease in EEM CSA was confirmed
in the planar IVUS analysis from OARS, a study of lesions
treated only using DCA (14). The decrease in EEM CSA was
greatest at the lesion site, but also appeared to extend into
contiguous reference segments. The decrease in EM CSA at
the reference segment correlated with the lesion site (r 5
0.608).
In the SURE Trial, 26 patients were treated with DCA, and
35 patients were treated with PTCA. In the planar analysis,
there was an early (within 1 month) increase in EEM CSA
followed by a late (1 to 6 months) decrease in EEM CSA (8).
Because the decrease in EEM CSA was shown to be a late
event (and preceded by an increase in EEM CSA), it was
shown to be distinct from early passive elastic recoil. Through-
out the duration of the SURE Trial, the change in lumen CSA
paralleled the changes in EEM CSA (r 5 0.789), not the
changes in P1M CSA (r 5 0.176).
Current analysis. There was one consistent methodologic
limitation in these previous studies. The results were depen-
dent on both the accurate identification of the same anatomic
cross section on serial ultrasound studies and on the selection
of the image slice for analysis—that is, the image slice with
smallest lumen CSA preintervention vs. postintervention vs.
follow-up. In three of these studies, the image slice with the
smallest lumen CSA at follow-up was analyzed; and in one
study the measurements from the image slice with the smallest
lumen CSA preintervention and at follow-up were averaged
throughout the time course of the study. The selection of the
image slice for analysis is important because the axial location
of the minimum lumen CSA has been shown to shift signifi-
cantly among these time points (14). The current three-
dimensional (volumetric) analysis was designed to address this
limitation.
Figure 4. In the overall cohort of 31
lesions, the change in lumen volume
correlated with the change in EEM
volume from postintervention to
follow-up (r 5 0.842, p , 0.0001), but
not with the change in P1M volume
(r 5 0.244, p 5 0.186).
Table 1. Serial Volumetric IVUS Results in All 31 Lesions
Preintervention Postintevention FU
D
(Postintervention
vs. FU)
p
(Postintervention
vs. FU)
EEM volume, mm3 315 6 97 351 6 98 318 6 112 233 6 38 , 0.0001
Lumen volume, mm3 115 6 44 175 6 44 145 6 61 230 6 24 , 0.0003
P1M volume, mm3 201 6 85 177 6 77 174 6 72 3 6 16 0.52
EEM 5 external elastic membrane; FU 5 follow-up; P1M 5 plaque1media.
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Early volumetric IVUS studies required laborious manual
analyses of many two-dimensional ultrasound images (29–33).
More recently, algorithms for automated quantification of the
lumen and arterial (EEM) volumes have been introduced
(15,16,24,34). The three-dimensional (volumetric) IVUS analysis
system used in the current study had been validated extensively. It
is more rapid than multiple planar measurements. Tissue-lumen
and media-adventitia borders are detected automatically and
edited manually in both cross-sectional and longitudinal sections.
This permits measurement of arterial, lumen, and plaque volumes
from a relatively larger number (n 5 10) of planar ultrasound
images per millimeter arterial length, or 200 images over the
length of artery analyzed.
The independent, blinded three-dimensional IVUS analysis
in the current study confirmed the importance of the decrease
in EEM as a mechanism of restenosis. The current analysis
also confirmed previous planar and volumetric IVUS reports
of the relative contributions of tissue removal and vessel
expansion to lumen enlargement during DCA procedures
(17,24,29).
Nomenclature and limitations of IVUS. Serial IVUS anal-
ysis can only measure net changes in P1M. Therefore, it
cannot isolate cellular proliferation, matrix deposition, athero-
sclerosis progression/regression, or plaque stabilization/
apoptosis from the overall net quantitative changes.
The IVUS analysis can only detect two borders accurately:
the lumen-intima interface and the media-adventitia interface.
Because the leading edge of the media cannot be detected
consistently, media thickness cannot be measured accurately.
Because the outer edge of the adventitia cannot be detected,
adventitial thickness cannot be measured. Finally, except for
venous structures and side branches, there are no consistent
peri-arterial structures or interfaces. Therefore, IVUS cannot
separate primary changes in EEM dimensions from changes in
EEM dimensions secondary to peri-vascular processes. In fact,
the decreases in EEM volumes reported in the current study
may actually reflect an increase in adventitial thickness or the
impact of peri-arterial scar formation.
Study limitations. This was only a subset of the overall
cohort of patients in OARS and the SURE Trial; however,
there were no differences between this subset and the entire
cohorts with regards to clinical, lesion site and procedural
variables. Also, there were only a few restenotic lesions at
follow-up. Global volumetric values over the 20-mm-long
segments could hide discordant localized behavior in individ-
ual cases with or without restenosis.
Differences in vascular tone could have contributed to
measurements of arterial and lumen dimensions. However, all
patients were studied only after administration of significant
doses of intracoronary nitroglycerin; and differences in vascu-
lar tone should not have affected measurement of P1M.
There were also potential limitations in the analysis system
and methodology employed. The movement of the IVUS
catheter during the cardiac cycle and the systolic-diastolic
vessel changes could have induced artifacts in the longitudi-
nally reconstructed views. Electrocardiographic (ECG) gated
acquisition is a promising, novel approach that can select
sequential images at the same time of the cardiac cycle,
thereby avoiding these longitudinal artifacts (24); however, this
technique was not available for the present study. Linear
three-dimensional analysis systems do not consider vessel
curvatures (35). Therefore, there may have been underestima-
tion of plaque at outer curvatures and overestimation of inner
curvatures. Combined use of data from angiography and IVUS
can overcome this problem (36), but this approach is not yet
feasible for clinical use. To surmount these limitations, our
study included only coronary segments with, at most, mildly
curved segments.
Conclusions. This serial three-dimensional (volumetric)
IVUS analysis confirmed previously published planar IVUS
analyses indicating that a decrease in dimensions is an impor-
tant mechanism of restenosis. Plaque regrowth did not play a
significant role in restenosis in the current study.
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